We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$99.1B
AUM Growth
+$7.92B
Cap. Flow
+$3.27B
Cap. Flow %
3.3%
Top 10 Hldgs %
23.39%
Holding
4,186
New
432
Increased
2,037
Reduced
1,399
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Financials 8.86%
3 Healthcare 8.09%
4 Industrials 6.83%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXMX
1776
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$2.91M ﹤0.01%
215,869
-10,941
-5% -$141K
EBS icon
1777
Emergent Biosolutions
EBS
$233M
$2.91M ﹤0.01%
31,297
+11,081
+55% +$1.13M
FRT icon
1778
Federal Realty Investment Trust
FRT
$10.2B
$2.9M ﹤0.01%
28,630
-5,103
-15% -$492K
IAT icon
1779
iShares US Regional Banks ETF
IAT
$689M
$2.9M ﹤0.01%
51,256
+28,449
+125% +$1.51M
GTHX
1780
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.89M ﹤0.01%
120,020
-24,933
-17% -$579K
CSL icon
1781
Carlisle Companies
CSL
$15.2B
$2.88M ﹤0.01%
17,491
-1,963
-10% -$301K
SABR icon
1782
Sabre
SABR
$831M
$2.86M ﹤0.01%
193,008
+119,496
+163% +$1.62M
RRC icon
1783
Range Resources
RRC
$9.39B
$2.86M ﹤0.01%
276,506
-57,608
-17% -$559K
QQQJ icon
1784
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.19B
$2.85M ﹤0.01%
89,669
+51,145
+133% +$1.67M
BFH icon
1785
Bread Financial
BFH
$4.46B
$2.85M ﹤0.01%
31,909
+6,175
+24% +$443K
IXJ icon
1786
iShares Global Healthcare ETF
IXJ
$4.23B
$2.85M ﹤0.01%
36,913
-948
-3% -$73K
KIE icon
1787
State Street SPDR S&P Insurance ETF
KIE
$681M
$2.84M ﹤0.01%
77,373
-4,397
-5% -$154K
MLN icon
1788
VanEck Long Muni ETF
MLN
$684M
$2.83M ﹤0.01%
132,398
-35,022
-21% -$757K
AU icon
1789
AngloGold Ashanti
AU
$48.1B
$2.83M ﹤0.01%
128,764
+57,475
+81% +$1.29M
PXI icon
1790
Invesco Dorsey Wright Energy Momentum ETF
PXI
$54.7M
$2.83M ﹤0.01%
+114,106
New +$2.67M
ITCI
1791
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.82M ﹤0.01%
83,229
+880
+1% +$30.5K
XITK icon
1792
State Street SPDR FactSet Innovative Technology ETF
XITK
$73.1M
$2.82M ﹤0.01%
13,502
+576
+4% +$131K
PRN icon
1793
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$442M
$2.82M ﹤0.01%
27,588
+4,343
+19% +$442K
SCHF icon
1794
Schwab International Equity ETF
SCHF
$69.3B
$2.82M ﹤0.01%
149,994
+3,638
+2% +$67.8K
MD icon
1795
Pediatrix Medical
MD
$2.15B
$2.81M ﹤0.01%
110,528
+3,182
+3% +$81.5K
FSLY icon
1796
Fastly Inc
FSLY
$4.78B
$2.81M ﹤0.01%
41,769
-7,263
-15% -$624K
BGC icon
1797
BGC Group
BGC
$5.12B
$2.81M ﹤0.01%
581,011
-298,860
-34% -$1.27M
TSLX icon
1798
Sixth Street Specialty
TSLX
$1.79B
$2.8M ﹤0.01%
133,251
+39,219
+42% +$842K
JPIN icon
1799
JPMorgan Diversified Return International Equity ETF
JPIN
$374M
$2.8M ﹤0.01%
45,872
-215,188
-82% -$13M
OMF icon
1800
OneMain Financial
OMF
$7.44B
$2.8M ﹤0.01%
52,078
+24,711
+90% +$1.28M

Similar funds

Raymond James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Raymond James & Associates held 4,186 positions worth $99.1B, up 8.7% from $91.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates deployed $3.27B of net new capital in Q1 2021, opening 432 new positions and adding to 2,037 existing holdings. Its largest new stake was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard High Dividend Yield ETF, an estimated $671M trimmed.

  • Raymond James & Associates's largest Q1 2021 buy was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2021, an estimated $1.36B increase.
  • Raymond James & Associates's biggest Q1 2021 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $671M.
  • Raymond James & Associates fully exited Sensient Technologies in Q1 2021, selling an estimated $15.6M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $99.1B portfolio in Q1 2021.
  • Raymond James & Associates opened 432 new positions and closed 199 in Q1 2021.
  • Raymond James & Associates's portfolio value rose 8.7% quarter-over-quarter to $99.1B.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.